Including risk information in character-space-limited (CSL) medical product communications increases consumer recognition of a product’s risks, a study funded by the FDA’s Office of Prescription Drug Promotion (OPDP) found. “Although it can be challenging to add risk information to CSL communications, this research supports FDA guidance on this topic and suggests that industr... Read More